Table: Hisamitsu -2023/24 group results

Hisamitsu Pharmaceutical Co

11/04/2024 07:00

Apr 11 (Reuters)- 
          Hisamitsu Pharmaceutical Co Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Feb 29, 2024    Feb 28, 2023   Feb 28, 2025     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            141.71          128.33         152.00                 
                 (+10.4 pct)     (+6.8 pct)     (+7.3 pct)               
  Operating         13.17           11.60          14.50                 
                 (+13.5 pct)     (+24.2 pct)    (+10.1 pct)              
  Recurring         19.65           16.05          18.90                 
                 (+22.4 pct)     (+27.0 pct)    (-3.8 pct)               
  Net
  Net               13.97           11.74          15.80                 
                 (+19.0 pct)     (+21.6 pct)    (+13.1 pct)              
  EPS            181.62 yen      148.01 yen     205.41 yen               
  EPS Diluted    181.42 yen      147.88 yen                              
  Ann Div         85.00 yen       84.50 yen      90.00 yen               
  -Q2 Div         42.50 yen       42.25 yen      45.00 yen               
  -Q4 Div         42.50 yen       42.25 yen      45.00 yen               
  
  NOTE - Hisamitsu Pharmaceutical Co Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T